FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($2.44), $0.70 better than the analyst estimate of ($3.14). Revenue for the quarter came in at $2.29 million versus the consensus estimate of $2.8 million.
I... More

